ID   TGW
AC   CVCL_1771
SY   TOG; TGW-nu; TGW-I-nu; TGW-nu-1
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471635
DR   CCLE; TGW_AUTONOMIC_GANGLIA
DR   Cell_Model_Passport; SIDM00324
DR   ChEMBL-Cells; CHEMBL3308792
DR   ChEMBL-Targets; CHEMBL1075600
DR   Cosmic; 801749
DR   Cosmic; 910780
DR   Cosmic; 920238
DR   Cosmic; 947703
DR   Cosmic; 1037349
DR   Cosmic; 1099146
DR   Cosmic; 1153801
DR   Cosmic; 2131589
DR   Cosmic-CLP; 910780
DR   DepMap; ACH-001674
DR   GDSC; 910780
DR   GEO; GSM314028
DR   GEO; GSM333815
DR   GEO; GSM1670542
DR   JCRB; JCRB0618
DR   LINCS_LDP; LCL-1962
DR   Lonza; 1191
DR   PharmacoDB; TGW_1592_2019
DR   Wikidata; Q54972266
RX   PubMed=2335222;
RX   PubMed=12210830;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-424.html
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: COSMIC cell lines project.
CC   Doubling time: 32 hours (lot 06012007), ~27 hours (lot 04172014) (JCRB).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=71.87%; East Asian, South=26.74%; South Asian=0.97%; European, North=0.42%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP; JCRB
ST   Amelogenin: X
ST   CSF1PO: 15
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   1Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-19; Version: 26
//
RX   PubMed=2335222; DOI=10.1016/0014-5793(90)81370-4;
RA   Tsuchida Y., Sekiguchi M., Kaneko Y., Kanda N.;
RT   "Origin of human neuroblastoma cell lines TGW and TNB1.";
RL   FEBS Lett. 263:191-191(1990).
//
RX   PubMed=12210830; DOI=10.1002/jnr.10330;
RA   Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.;
RT   "Malignant rhabdoid tumor shows incomplete neural characteristics as
RT   revealed by expression of SNARE complex.";
RL   J. Neurosci. Res. 69:642-652(2002).
//
RX   PubMed=18923524; DOI=10.1038/nature07399;
RA   Chen Y., Takita J., Choi Y.L., Kato M., Ohira M., Sanada M., Wang L.,
RA   Soda M., Kikuchi A., Igarashi T., Nakagawara A., Hayashi Y., Mano H.,
RA   Ogawa S.;
RT   "Oncogenic mutations of ALK kinase in neuroblastoma.";
RL   Nature 455:971-974(2008).
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M.,
RA   Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M.,
RA   Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A.,
RA   Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//